Rivaroxaban and Aspirin in Patients with Symptomatic Lower Extremity Peripheral Artery Disease A Subanalysis of the COMPASS Randomized Clinical Trial
There is a high risk of major vascular events in patients with symptomatic lower extremity peripheral artery disease (LE-PAD). There are fewer known clinical...